BOSTON--(BUSINESS WIRE)--
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. | KEY INFORMATION | ||||||||||||||
Name of person dealing | Wellington Management Company, LLP | ||||||||||||||
Company dealt in | Medtronic, Inc. | ||||||||||||||
Class of relevant security to which the
dealings being disclosed relate |
Common Stock | ||||||||||||||
Date of dealing | 29 August 2014 | ||||||||||||||
2. | INTERESTS AND SHORT POSITIONS | ||||||||||||||
(a) |
Interests and short positions (following dealing) in the class of
relevant security
dealt in |
||||||||||||||
Long | Short | ||||||||||||||
Number | (%) | Number | (%) | ||||||||||||
(1) | Relevant securities | 54,393,288 shares | 5.55 % | ||||||||||||
(2) | Derivatives (other than options): | ||||||||||||||
(3) | Options and agreements to purchase/sell: | ||||||||||||||
Total | 54,393,288 shares | 5.55 % | |||||||||||||
(b) |
Interests and short positions in relevant securities of the
company, other than the
class dealt in |
||||||||||||||
Long | Short | ||||||||||||||
Number | (%) | Number | (%) | ||||||||||||
(1) | Relevant securities | ||||||||||||||
(2) | Derivatives (other than options): | ||||||||||||||
(3) | Options and agreements to purchase/sell: | ||||||||||||||
Total |
3. | DEALINGS | ||||||||||||||||||||||||
(a) | Purchases and sales | ||||||||||||||||||||||||
Purchase/sale | Number of relevant securities | Price per unit | |||||||||||||||||||||||
Sale | 600 shares | 63.6342 USD | |||||||||||||||||||||||
Sale | 2,820 shares | 63.8500 USD | |||||||||||||||||||||||
Sale | 2,840 shares | 63.6607 USD | |||||||||||||||||||||||
Sale | 3,233 shares | 63.6863 USD | |||||||||||||||||||||||
Sale | 6,205 shares | 63.4200 USD | |||||||||||||||||||||||
Sale | 9,936 shares | 63.0780 USD | |||||||||||||||||||||||
(b) | Derivatives transactions (other than options transactions) | ||||||||||||||||||||||||
Product name
e.g. CFD |
Nature of transaction | Number of relevant securities | Price per unit | ||||||||||||||||||||||
(c) | Options transactions in respect of existing relevant securities | ||||||||||||||||||||||||
(i) | Writing, selling, purchasing or varying | ||||||||||||||||||||||||
Product name e.g. call option | Writing, purchasing, selling, varying etc. | Number of securities to which the option relates | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/ received per unit | |||||||||||||||||||
(ii) | Exercising | ||||||||||||||||||||||||
Product name
e.g. call option |
Number of securities | Exercise price per unit | |||||||||||||||||||||||
(d) | Other dealings (including subscribing for new securities) | ||||||||||||||||||||||||
Nature of transaction | Details | Price per unit (if applicable) |
4. | OTHER INFORMATION | |||
Agreements, arrangements or understandings relating to options or derivatives | ||||
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. | ||||
None | ||||
Is a Supplemental Form 8 attached? | NO | |||
Date of disclosure | 01 September 2014 | |||
Contact name | John D. Norberg | |||
Telephone number | 617-790-7265 | |||
If a connected EFM, name of offeree/offeror with which connected | ||||
If a connected EFM, state nature of connection |
Category Code: RET
Sequence Number: 431030
Time of Receipt (offset from UTC): 20140901T120014+0100